Cannabis vs. COVID: What the research is showing episode artwork

EPISODE · Jan 19, 2022 · 24 MIN

Cannabis vs. COVID: What the research is showing

from Front Burner

A study last week from two Oregon universities has generated a lot of buzz, after findings suggested that some cannabis compounds may be able to block the SARS-CoV-2 virus from entering human cells. It adds to a growing body of research on cannabis and the coronavirus, as studies from around the world — including from Canada — have found that the cannabis compound CBD may be effective in helping treat some of the virus’s most deadly symptoms. Today, Katie MacBride, a health science reporter at the online magazine Inverse, joins us for a deep dive into what the research says — and doesn’t say — about cannabis and COVID-19. CORRECTION: This episode misstated that mRNA vaccines are designed to attach to the SARS-CoV-2 spike protein. To be clear, mRNA vaccines instruct the body's cells to make harmless copies of the spike protein, causing the body to produce antibodies which then attach to the proteins.

Episode metadata supplied by the publisher feed · Published Jan 19, 2022

Embed this episode

Ready to play

Cannabis vs. COVID: What the research is showing

0:00 24:36

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Front Burner?

This episode is 24 minutes long.

When was this Front Burner episode published?

This episode was published on January 19, 2022.

Can I download this Front Burner episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!